NeuroSense Therapeutics Ltd.
NRSN
$1.08
-$0.72-40.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.38M | 1.21M | 2.64M | 4.76M | |
| Total Receivables | 164.00K | 376.00K | 166.00K | 309.00K | |
| Inventory | 738.00K | -- | -- | -- | |
| Prepaid Expenses | 87.00K | -- | 70.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 35.00K | 35.00K | 40.00K | 37.00K | |
| Total Current Assets | 4.40M | 1.62M | 2.92M | 5.11M | |
|
|
|||||
| Total Current Assets | 4.40M | 1.62M | 2.92M | 5.11M | |
| Net Property, Plant & Equipment | 150.00K | 200.00K | 247.00K | 260.00K | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 23.00K | 22.00K | 22.00K | 21.00K | |
| Total Assets | 4.58M | 1.84M | 3.19M | 5.39M | |
|
|
|||||
| Total Accounts Payable | 1.16M | 1.48M | 1.46M | 913.00K | |
| Total Accrued Expenses | 759.00K | -- | 1.93M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 73.00K | -- | 69.00K | -- | |
| Total Finance Division Other Current Liabilities | -- | 2.03M | -- | 1.90M | |
| Total Other Current Liabilities | -- | 2.03M | -- | 1.90M | |
| Total Current Liabilities | 1.99M | 3.51M | 3.46M | 2.81M | |
|
|
|||||
| Total Current Liabilities | 1.99M | 3.51M | 3.46M | 2.81M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | 36.00K | 73.00K | 84.00K | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | 1.41M | 2.69M | |
| Total Liabilities | 1.99M | 3.54M | 4.94M | 5.58M | |
|
|
|||||
| Common Stock & APIC | 39.24M | 30.68M | 24.36M | 28.92M | |
| Retained Earnings | -36.66M | -32.38M | -26.12M | -29.12M | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 2.58M | -1.70M | -1.76M | -196.00K | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 2.58M | -1.70M | -1.76M | -196.00K | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 2.58M | -1.70M | -1.76M | -196.00K | |
|
|
|||||